The global Sodium Chloride Market was valued at USD 19,845.8...
Read MoreThe global Veterinary CT Scanner market was valued at USD 501.6 million in 2025 and is projected to reach USD 961.7 million by 2035, expanding at a CAGR of 7.5%. Veterinary computed tomography encompasses 16-slice, 32-slice, 64-slice, and 128-slice-and-above helical CT systems, cone beam CT (CBCT), multi-detector CT (MDCT), and portable/mobile CT units deployed at companion animal specialist hospitals, academic veterinary institutions, and equine referral centres for neurology, oncology, orthopaedic, dental, and cardiovascular imaging applications.
The market is structurally driven by the expansion of corporate companion animal specialist hospital networks — BluePearl, Ethos Veterinary Health, VCA Specialty — that are installing 64-slice and above CT systems as standard diagnostic infrastructure in suburban referral centres previously dependent on academic hospital CT access. The parallel rise in companion animal oncology diagnosis, enabled by liquid biopsy cancer screening platforms entering routine wellness visit protocols, is accelerating CT staging study volume as confirmed cancer patients require cross-sectional imaging before treatment initiation.
What is the confirmed 2025 market size and projected 2035 value for the veterinary CT scanner market?
The market was valued at USD 501.6 million in 2025 and is forecast to reach USD 961.7 million by 2035 at a 7.5% CAGR. Companion animal (small animal) CT constitutes the dominant application segment by installed unit count. 64-slice and above systems represent the fastest-growing product tier by capital value. Neurology, oncology, and orthopaedics are the three highest-volume clinical applications. North America accounts for the largest geographic share; Asia-Pacific is the fastest-growing region.
Why are 64-slice and 128-slice CT systems replacing legacy 16-slice units in veterinary practice?
64-slice and 128-slice MDCT systems provide isotropic voxel resolution enabling diagnostic-quality multiplanar reconstruction of small companion animal anatomy — critical for intranasal tumour staging, intracranial lesion characterisation, and tibial plateau angle measurement for TPLO surgical planning — at gantry rotation speeds short enough to freeze cardiac motion without breath-hold in anaesthetised patients. Legacy 16-slice systems cannot achieve the resolution or reconstruction quality required for companion animal oncology staging or neurosurgical planning, driving replacement cycles across corporate hospital networks upgrading to current clinical standards.
How does companion animal oncology screening drive CT staging study volume?
Liquid biopsy cancer screening platforms entering companion animal annual wellness protocols are identifying dogs with confirmed lymphoma, mast cell tumours, and other cancers before clinical signs appear. Each confirmed cancer diagnosis generates a CT staging study — thorax, abdomen, and pelvis for lymphoma; regional lymph node and pulmonary CT for mast cell disease — worth USD 1,500–3,500 per case in specialist hospital fees. As cancer screening adoption grows across North American and European companion animal practices, the volume of CT staging studies grows proportionately, sustaining above-baseline CT scanner utilisation at specialist referral centres.
What is driving portable and mobile CT adoption in veterinary markets?
Portable CT scanners enabling standing equine distal limb imaging — without general anaesthesia and with the horse bearing weight on the affected limb — are the fastest-growing veterinary CT product by unit growth rate. Traditional equine CT required general anaesthesia with the horse in dorsal recumbency; standing CT eliminates anaesthetic risk, reduces procedure time to under 30 minutes, and enables imaging of the loaded limb in the functional position relevant to performance horse lameness diagnosis. Portable units are deployed at equine referral hospitals, racecourse veterinary facilities, and large equine practices serving competition horses.
Which regional markets are growing fastest, and what is driving Asia-Pacific expansion?
Asia-Pacific is the fastest-growing regional veterinary CT scanner market, driven by urban companion animal ownership expansion in China, South Korea, and Japan — where pet ownership has grown at 10–15% annually — combined with capital investment in companion animal specialist hospital infrastructure by corporate veterinary groups including Shanghai-based chains and Korean veterinary hospital networks. Japan and Australia contribute significant volumes from established companion animal specialist practice networks. The Middle East and Latin America represent emerging markets with growing specialist hospital investment.
How does cone beam CT (CBCT) expand veterinary dental imaging capability above conventional radiography?
Veterinary CBCT systems — providing three-dimensional dental and maxillofacial imaging at radiation doses significantly below conventional CT — are enabling precise root canal treatment planning, jaw tumour extent assessment, and tooth root disease characterisation in cats and dogs that two-dimensional dental radiography cannot provide. CBCT is particularly valuable in feline tooth resorption staging, where three-dimensional root assessment determines extraction technique (simple versus surgical) and reduces operative complications. CBCT adoption is growing at veterinary dental specialist centres and progressive general companion animal practices investing in comprehensive dental radiography capability.
Key Players: GE HealthCare Technologies (GEHC), Siemens Healthineers, Mindray Medical International, Animage (Neurologica), Epica Medical Innovations, Canon Medical Systems, FUJIFILM Holdings, Imotek International, Hitachi Medical Systems, and Hallmarq Veterinary Imaging
Recent Developments
The Veterinary CT Scanner market’s 7.5% CAGR to USD 961.7 million by 2035 is underpinned by the convergence of three durable structural growth drivers: corporate specialist hospital network expansion installing 64-slice CT as standard infrastructure, companion animal cancer screening creating above-baseline staging study demand, and portable equine standing CT opening an anaesthesia-free imaging market. GE HealthCare and Siemens Healthineers‘s installed base at academic and corporate specialist hospitals, combined with Hallmarq‘s standing equine CT leadership, confirm that the veterinary CT scanner market will sustain above-medical-device-sector-average CAGR through 2035 as companion animal specialist medicine matures toward human-equivalent imaging standards.
Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.
The global Sodium Chloride Market was valued at USD 19,845.8...
Read MoreThe global Isononanoic Acid Market was valued at USD 384.9...
Read MoreThe global Industrial Water Treatment Chemicals Market was valued at...
Read MoreWhatsApp us